Goldstein Advisors, LLC

Position in NVO — Novo Nordisk A S

CIK 1963807 Madison, WI

Position in NVO

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$218,127

New position

Shares Held

4,550

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

#1,001

of 1,348 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Goldstein Advisors, LLC holds $3,737,042 across 6 Drug Manufacturers - General names. NVO ranks #6 (5.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	3,947	$1,002,419
2	ABBV	AbbVie Inc.	3,951	$994,229
3	LLY	ELI LILLY & Co	525	$629,700
4	MRK	Merck & Co., Inc.	4,434	$569,769
5	GILD	Gilead Sciences, Inc.	2,555	$322,798
6	NVO	Novo Nordisk A S This page	4,550	$218,127

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$218,127	4,550	—	Shares	Sole	2026-07-20
No filing history on record for this holder in this stock.